Analysis of US VAERS Vaccine Adverse Reactions Data by Biostatistician Christine Cotton Part 2

We encourage readers to watch Analysis of US VAERS Vaccine Adverse Reactions Data by Biostatistician Christine Cotton Part 1 before watching Part 2.

In a valuable and informative interview with the UK Column, Christine Cotton divided a presentation of her work into two parts. Part 1 began with an introduction to herself and her professional work as a biostatistician. This was followed by a detailed analysis of the complex procedures and regulations required of pharmaceutical companies in developing new vaccines.

The results of her analysis of the procedural and regulatory steps taken to introduce Covid-19 emergency vaccines led Christine to conclude that it was simply not possible to develop, test and unleash the suite of Covid-19 vaccines on the US and world population in a manner and timeframe which met all the then existing public health and vaccine safety constraints, checks and regulations. In short, the development and vaccine roll-out was just too fast to justify the vaccine safety and efficacy claims made.

Christine concludes from her analysis of the implementation of the Covid-19 vaccination programme and the VAERS data itself that the vaccines carry significant health risks to all members of the public, be they children, adults or the elderly. Within this cross-section of society, additional risks are identifiable for pregnant women and their babies. The risks deserve special attention when it is realised that they include life changing disabilities and even death.

Analysis of US VAERS Vaccine Adverse Reactions Data by Biostatistician Christine Cotton Part 2 focuses on the identification of key vaccine adverse health risks within the body of the VAERS data. Christine Cotton's findings make stark reading, set against the continuing claim by the US Government and US public health agencies that vaccines are safe and that their benefits outweigh the risks.